Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

AEterna Zentaris Inc T.AEZ

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  AEZS

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology.
Price: $1.26 | Change: +$0.07 | %Change: +5.88%
Volume: 833 | Day High/Low: 1.26/1.21 | 52 Week High/Low: 1.81/0.93
View modes: 
0 stars

RE:RE:RE:what's up here today?

bail............  rate and reply
0 stars

RE:RE:what's up here today?

Nothing concrete to share except an opinion....when I see a big sell off like this, I consider there as being only 2 real possibilities...either there's bad news coming and some 'in the know' more
0 stars

RE:what's up here today?

Same question here! It was moving nicely for a while. If anyone has info., pls. share?  rate and reply
0 stars

what's up here today?

...interested, what's up? Nosleep  rate and reply
0 stars

That spam message helped....

I put AEZ on watch a few months back...but with so many stocks vying for my attention, sometimes they fall through the cracks.  I had forgotten about AEZ until that spam msg (since deleted) more
0 stars

Ready for a Golden Cross?

Looks like it to me...  rate and reply
0 stars

PP Closed

Price firming up nice. $1.20 now.  rate and reply
0.5 stars

RE:new finance 1.15

Quick close on this PP ... price won't stay at this level for very long.  rate and reply
0 stars

new finance 1.15

1.15 finance with a freebie warrent.  new price to settle at 1.05-1.10 here factoring in a warrent premium, or is there reason for today buyers to pay above finance price?  rate and reply
0 stars


Very difficult one to forecast because of poor drug visibility. Strong balance sheet is very  positive.  rate and reply

How to invest in private equity without writing a $1 million check.

Click here to watch the video